Ole De Backer1, MD, PhD; Janarthanan Sathananthan2, MPH, MBChB; Uri Landes3, MD; Haim D. Danenberg3, MD; John Webb2, MD; Lars Sondergaard4, MD, DMSc
1. The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; 2. St. Paul’s Hospital, Vancouver, BC, Canada; 3. Edith Wolfson Medical Center, Holon, Israel and Tel-Aviv University, Tel Aviv, Israel; 4. Abbott Structural Heart, Santa Clara, CA, USA
Transcatheter aortic valve implantation (TAVI) is increasingly used to treat younger patients with longer life expectancy. Consequently, it can be expected that a considerable portion of these patients will outlive their transcatheter aortic valve (TAV). In the event of TAV failure, redo-TAVI may be the preferred solution. However, redo-TAVI outcomes may vary depending on the patient’s anatomy and TAV-in-TAV combination. In this viewpoint, we highlight different TAV stent designs and leaflet positions and discuss their impact on specific aspects of TAV-in-TAV.
A first aspect to consider when planning redo-TAVI is that the leaflets of the first index ...